SHARE EXCHANGE AGREEMENTShare Exchange Agreement • July 22nd, 2008 • Universal Fog Inc • Industrial & commercial fans & blowers & air purifing equip • Delaware
Contract Type FiledJuly 22nd, 2008 Company Industry JurisdictionSHARE EXCHANGE AGREEMENT (THIS "AGREEMENT") IS MADE THIS 15TH DAY OF OCTOBER 2007, BY AND BETWEEN UNIVERSAL FOG, INC., A DELAWARE CORPORATION (“UFOG”); THOMAS BONTEMS, THE CHIEF EXECUTIVE OFFICER OF UFOG (“BONTEMS”); SUN, XIN, A CITIZEN AND RESIDENT OF THE PEOPLE’S REPUBLIC OF CHINA AND MAJORITY SHAREHOLDER OF UFOG (THE “MAJORITY SHAREHOLDER”) AND 100% OWNER OF THE SHARE CAPITAL OF CHINA HEALTH INDUSTRIES HOLDINGS LIMITED; CHINA HEALTH INDUSTRIES HOLDINGS LIMITED, A CORPORATION ORGANIZED UNDER THE LAWS OF THE HONG KONG SAR OF THE PEOPLE’S REPUBLIC OF CHINA (“CHINA HEALTH”) AND THE OWNER OF 100% OF THE SHARE CAPITAL OF HARBIN HUMANKIND BIOLOGY TECHNOLOGY CO. LIMITED; AND HARBIN HUMANKIND BIOLOGY TECHNOLOGY CO. LIMITED, A CORPORATION ORGANIZED UNDER THE LAWS OF THE PEOPLE’S REPUBLIC OF CHINA (“HARBIN HUMANKIND”)(CHINA HEALTH AND HARBIN HUMANKIND BEING HEREINAFTER REFERRED TO AS THE “HARBIN SUBSIDIARIES”); ALL OF WHOM EXECUTE AND DELIVER THIS AGREEMENT, BASED ON THE FOLLOWING:
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 20th, 2008 • Universal Fog Inc • Industrial & commercial fans & blowers & air purifing equip • Delaware
Contract Type FiledFebruary 20th, 2008 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 10, 2007, by and among Universal Fog, Inc., a Delaware corporation (the “Company”), Thomas Bontems, a citizen and resident of the state of Arizona (“Bontems”), and Sun, Xin, a resident and citizen of Harbin, Heilongjiang Province, People’s Republic of China (“Buyer”).
ASSET PURCHASE AND SALE AGREEMENTAsset Purchase and Sale Agreement • February 20th, 2008 • Universal Fog Inc • Industrial & commercial fans & blowers & air purifing equip • Arizona
Contract Type FiledFebruary 20th, 2008 Company Industry JurisdictionTHIS ASSET PURCHASE AND SALE AGREEMENT (this “Agreement”) is made and entered into as of September 10, 2007, by and among Universal Fog, Inc., a corporation organized and existing under the laws of Delaware (“Seller”), and Universal Fog Systems, Inc., an Arizona corporation (“Buyer”). Capitalized terms used and not otherwise defined herein shall have the definitions assigned thereto in Section 10 below.
STOCK PURCHASE AGREEMENT AND SHARE EXCHANGE by and among EDMONDS 6, INC. a Delaware Corporation and UNIVERSAL FOG, INC. an Arizona Corporation effective as of May 9, 2005Stock Purchase Agreement and Share Exchange • May 12th, 2005 • Edmonds 6 Inc. • Non-operating establishments • Arizona
Contract Type FiledMay 12th, 2005 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT AND SHARE EXCHANGE, made and entered into this May 9, 2005, by and among Edmonds 6, Inc., a Delaware corporation with its principal place of business located at 1808 South 1st Avenue, Phoenix, Arizona 85003 (“EDMONDS”); Universal Fog, Inc., an Arizona corporation with its principal place of business located at 1808 South 1st Avenue, Phoenix, Arizona 85003 (“UNIVERSAL FOG”) and the shareholders of UNIVERSAL FOG (“Shareholders”) as set forth on Exhibit A attached hereto (collectively UNIVERSAL FOG and the shareholders of UNIVERSAL FOG shall be known as the “UNIVERSAL FOG Group”).
Loan AgreementLoan Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the basis of equality, voluntariness and negotiation, both Party A and Party B enter into this agreement about the loan.
Supplementary AgreementSupplementary Agreement • November 14th, 2016 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 14th, 2016 Company IndustryOn December 24, 2014, Party A, Party B, Party C, and Party D (the “Four Parties”) entered into a stock transfer agreement (the “Stock Transfer Agreement”) and on February 9, 2015, the Four Parties entered into a supplementary agreement (the “2015 Supplementary Agreement”). In order to accelerate the transfer of core assets, the Four Parties entered into the following terms after friendly negotiation.
Health Food Technology Transfer AgreementHealth Food Technology Transfer Agreement • October 15th, 2013 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 15th, 2013 Company IndustryProject Name: The transfer of the twelve health food approval numbers of Health Foods, including Dr. Xiao Brand Honeysuckle Pearl Capsule, Dr. Xiao Brand Multivitamin Tablet, Dr. Xiao Brand Zhengdian Capsule, Dr. Xiao Brand Shengui Capsule, Dr. Xiao Brand Multivitamin Tablet (Woman), Dr. Xiao Brand Shikong Soft Capsule, Dr. Xiao Brand Huangjingdanggui Tablet, Dr. Xiao Brand Xingxing Soft Capsule, Dr. Xiao Brand Vitamin A Fish Oil Soft Capsule, Dr. Xiao Brand Colon Cleanser Granules, Dr. Xiao Brand Jianli Soft Capsule and LB Brand Xinpin Capsule, and the trademark ownership of Dr. Xiao’s No.5 and No.30 category product and LB’s No.30 category product.
RESTRICTIVE STOCK AWARD AGREEMENT pursuant to theRestrictive Stock Award Agreement • April 2nd, 2015 • China Health Industries Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 2nd, 2015 Company Industry JurisdictionTHE RESTRICTED SHARE AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between China Health Industries Holdings, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the 2015 Equity Incentive Plan of the Company, as in effect and as amended from time to time (the “Plan”); and
Purchase AgreementPurchase Agreement • September 29th, 2014 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 29th, 2014 Company IndustryThis purchase Agreement (the “Agreement”) was negotiated and entered by Shukui Wang (the “Supplier”) and Harbin Humankind Biology Technology Co. Limited (the “Purchaser”).
Loan AgreementLoan Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the basis of equality, voluntariness and negotiation, both Party A and Party B enter into this agreement about the loan.
Agreement between Universal Fog, Inc. and Tom BontemsUniversal Fog Inc • January 27th, 2006 • Industrial & commercial fans & blowers & air purifing equip • Arizona
Company FiledJanuary 27th, 2006 Industry Jurisdiction
UNIVERSAL FOG EXCLUSIVE DEALER AGREEMENTExclusive Dealer Agreement • April 24th, 2006 • Universal Fog Inc • Industrial & commercial fans & blowers & air purifing equip
Contract Type FiledApril 24th, 2006 Company Industryorganized and existing under the laws of the State of Arizona, with a principal place of business at 1808 S. 1st. Ave. Phoenix. AZ 85003 (“UNIVERSAL FOG”) and Universal Fog T&L, INC., Kay Fogg, Inc, and Mark Kay individually with a
Cooperative AgreementCooperative Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the principles of mutual reliance, mutual promotion, mutual cooperation and common development, both Party A and Party B come into the following agreement after friendly negotiation, under the background that government lead and coordinate enterprises to cooperate with each other to develop local agriculture deep processing and the related industries.
Technology Development AgreementTechnology Development Agreement • July 18th, 2011 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 18th, 2011 Company IndustryParty A entrusts Party B to develop Qunle Xuyuan Tablet (Tentative) and apply for registration on behalf of Party A. With the function of improving hypoxia tolerance, Qunle Xuyuan Tablet is made from Ginkgo Leaf, Gynostemma Pentaphyllum, Puerariae Extract, Panax Quinquefolius, Mint, Cinnamomum Cassia and Amomum Cardamomum etc. Party A shall pay Party B fees and compensations incurred during technology development and registration. Party B accepts the contract and shall undertake to conduct the technology development and apply for registration. Based on mutual negotiation, the parties hereby enter into this agreement (“Agreement”) according to People’s Republic of China Contract Law. Both parties shall abide by the terms in this Agreement.
Land Use AgreementLand Use Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryBased on the principles of equality, voluntariness, compensating and good faith, the transferor and the transferee entered into this agreement.
Loan AgreementLoan Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the basis of equality, voluntariness and negotiation, both Party A and Party B enter into this agreement about the loan.
Loan AgreementLoan Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the basis of equality, voluntariness and negotiation, both Party A and Party B enter into this agreement about the loan.
Loan AgreementLoan Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the basis of equality, voluntariness and negotiation, both Party A and Party B enter into this agreement about the loan.
Financial Management AgreementManagement Agreement • September 28th, 2016 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 28th, 2016 Company IndustryIn order to enhance business cooperation between Party A and Party B, both parties enter into the following terms on an equal, mutual-beneficial and voluntary basis.
Stock Transfer AgreementStock Transfer Agreement • July 17th, 2024 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 17th, 2024 Company IndustryWhereas Party A legally owns 1% of equity stock of Harbin Humankind Biology Technology Co., Limited (hereinafter referred as “the Company”) and has decided to transfer all 1% of stock equity, and that the shareholders meetings of the Company have approved the transfer.
Supplementary AgreementSupplementary Agreement • February 13th, 2015 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 13th, 2015 Company IndustryIn view of the four parties signed the Stock Transfer Agreement (the “Original Agreement”) on December 24, 2014, the substance of the Agreement is that Party A purchases drug approval numbers from Party C. If the equity transfer were consummated, the Transferee should have involved in monthly tax declaration, employee insurance and housing fund, changes in tax registration, cancel of business license after the drug transfer-out and tax audits, etc., all of which will be complicated. After friendly negotiation, the four parities enter into this supplementary agreement (the “Agreement”).
Loan AgreementLoan Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the basis of equality, voluntariness and negotiation, both Party A and Party B enter into this agreement about the loan.
Loan AgreementLoan Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the basis of equality, voluntariness and negotiation, both Party A and Party B enter into this agreement about the loan.
Stock Transfer AgreementTransfer Agreement • December 31st, 2014 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 31st, 2014 Company IndustryParty A: Xiuzheng Pharmaceutical Group Co., Ltd Legal Representative: Laigui Xiu Address: No. 36 Xiuzheng Road, Tonghua City, Jilin Province
Loan AgreementLoan Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the basis of equality, voluntariness and negotiation, both Party A and Party B enter into this agreement about the loan.
AGREEMENTAgreement • June 8th, 2006 • Universal Fog Inc • Industrial & commercial fans & blowers & air purifing equip • Illinois
Contract Type FiledJune 8th, 2006 Company Industry JurisdictionCorp., a validly existing Illinois corporation and Sundown Designs, Inc., a validly existing Illinois corporation hereafter collectively “Manufacturer” and Tom Bontems, an individual and Universal Fog Inc., a validly existing Arizona Corporation, hereafter “Distributor”.
Lease AgreementLease Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryBased on the principls of mutual cooperation, mutual benefit and common development, both Party A and Party B signed this agreement after friendly negotiation. The content of this agreement is as follows:
Loan AgreementLoan Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the basis of equality, voluntariness and negotiation, both Party A and Party B enter into this agreement about the loan.
Loan AgreementLoan Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the basis of equality, voluntariness and negotiation, both Party A and Party B enter into this agreement about the loan.
Land Purchase AgreementPurchase Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryBased on the principles of equality, voluntariness, compensating and good faith, the transferor and the transferee entered into this agreement.
Financial Management AgreementFinancial Management Agreement • October 13th, 2015 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 13th, 2015 Company IndustryIn order to enhance business cooperation between Party A and Party B, both parties enter into the following terms on an equal, mutual-beneficial and voluntary basis.
Loan AgreementLoan Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryOn the basis of equality, voluntariness and negotiation, both Party A and Party B enter into this agreement about the loan.
Purchase AgreementPurchase Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustrySupplier shall be responsible for delivering the goods to the place of purchaser and afford the transportation expenses.
SHARE TRANSFER AGREEMENTShare Transfer Agreement • December 9th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 9th, 2010 Company IndustryTHIS SHARE TRANSFER AGREEMENT (this "Agreement") is dated as of August 18, 2009, by and among Harbin Humankind Biology Technology Co. Limited (the "Transferee", or "Humankind") and all shareholders ("Transferor") of Heilongjiang Tiefeng Rice Company Limited ("Tiefeng" or the "Target Company").
Technology Transfer AgreementTechnology Transfer Agreement • November 16th, 2010 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2010 Company IndustryBoth parties negotiate and sign this agreement about transfer of ownership of Jindelikang Propolis and Black Ants Capsule (approval number: GSJZ G20040906 ).